Abstract
Aims: To explore the ATF2 expression of preeclampsia patients and investigate whether the level of ATF2 expression impacted the low-dose aspirin treatment of preeclampsia patients.
Background: Preeclampsia is a severe pregnancy-related hypertension disorder and refers to hypertension.
Objective: This study was designed to explore the activating transcription factor 2 (ATF2) expression of preeclampsia patients and investigate whether the level of ATF2 expression impacted the low-dose aspirin treatment of preeclampsia patients.
Methods: Firstly, we collected the plasma of normal and preeclampsia pregnancies and quantified the expressions of ATF2 by ELISA. Then we quantified the expression of the three downstream target genes of ATF2 (IL-8, IL-6 and MMP-2). Finally, we collected and quantified the interventional and observational group plasma. All data were compared by t-test (p<0.05).
Results: ATF2 and its target genes (IL-6, IL-8 and MMP-2) were upregulated in preeclampsia patients. In addition, ATF2 and its target genes were downregulated in the interventional group (LDA-treated group).
Conclusion: Our results indicated that LDA could inhibit ATF2 expression in preeclampsia. It suggests that ATF2 may be a potential target of LDA in the prevention of preeclampsia.
Keywords: Congenital adrenal hyperplasia, 11-beta hydroxylase deficiency, 11-deoxycortysol, CYP11B1 gene, mineralocorticoid pressure levels, ATF2.
[http://dx.doi.org/10.1161/CIRCRESAHA.118.313276] [PMID: 30920918]
[http://dx.doi.org/10.1016/j.ajog.2008.07.048]
[http://dx.doi.org/10.37175/stemedicine.v3i3.129]
[PMID: 21822394]
[http://dx.doi.org/10.1016/j.humimm.2021.01.004] [PMID: 33551128]
[http://dx.doi.org/10.1007/s40265-017-0823-0] [PMID: 29039130]
[http://dx.doi.org/10.1016/j.semnephrol.2017.05.011] [PMID: 28711078]
[http://dx.doi.org/10.1002/uog.12421] [PMID: 23362106]
[http://dx.doi.org/10.1016/j.biopha.2019.108953] [PMID: 31075732]
[http://dx.doi.org/10.1016/j.phrs.2017.02.004] [PMID: 28212892]
[http://dx.doi.org/10.1371/journal.pone.0173711] [PMID: 28358847]
[http://dx.doi.org/10.1155/2014/950472] [PMID: 25049453]
[http://dx.doi.org/10.1038/nrc2681] [PMID: 20029425]
[http://dx.doi.org/10.1007/s12253-014-9872-9] [PMID: 25583406]
[http://dx.doi.org/10.2174/138955709788681663] [PMID: 19601892]
[http://dx.doi.org/10.1016/j.preghy.2017.07.001] [PMID: 29153661]
[http://dx.doi.org/10.1016/j.preghy.2013.04.006] [PMID: 26105838]
[http://dx.doi.org/10.1111/ajo.12126] [PMID: 23919594]
[http://dx.doi.org/10.1080/14767058.2019.1611768] [PMID: 31018725]
[http://dx.doi.org/10.1111/j.1471-0528.1986.tb07830.x] [PMID: 3790464]
[http://dx.doi.org/10.1158/0008-5472.CAN-06-1461] [PMID: 17079470]
[http://dx.doi.org/10.1074/jbc.274.10.6783] [PMID: 10037779]
[http://dx.doi.org/10.4049/jimmunol.180.7.5017] [PMID: 18354227]
[http://dx.doi.org/10.1002/jcla.22834] [PMID: 30666720]
[http://dx.doi.org/10.1155/2020/8369645] [PMID: 33381317]
[http://dx.doi.org/10.1097/MD.0000000000005537] [PMID: 28033248]
[http://dx.doi.org/10.1097/AOG.0b013e3181e9322a] [PMID: 20664402]
[http://dx.doi.org/10.1136/bmj.1.6111.467] [PMID: 626836]
[http://dx.doi.org/10.1055/s-0038-1649882] [PMID: 8560414]
[http://dx.doi.org/10.1016/0002-9378(88)90560-1] [PMID: 3061295]
[http://dx.doi.org/10.2353/ajpath.2007.061035] [PMID: 17456758]
[http://dx.doi.org/10.1016/S0140-6736(99)80002-6] [PMID: 10485715]
[http://dx.doi.org/10.1155/2012/734865] [PMID: 22110537]
[http://dx.doi.org/10.1053/plac.2002.0930] [PMID: 12842410]
[http://dx.doi.org/10.1126/science.1281554] [PMID: 1281554]
[http://dx.doi.org/10.1016/j.cyto.2020.155252] [PMID: 32818703]
[http://dx.doi.org/10.1177/1933719115607998] [PMID: 26438597]